Sanara Operating Cycle from 2010 to 2026
| SMTI Stock | USD 20.44 0.11 0.54% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 207.59 | Current Value 385.53 | Quarterly Volatility 73.7157273 |
Check Sanara Medtech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanara Medtech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.9 M, Interest Expense of 3.8 M or Total Revenue of 104.7 M, as well as many indicators such as Price To Sales Ratio of 3.55, Dividend Yield of 0.0324 or PTB Ratio of 6.76. Sanara financial statements analysis is a perfect complement when working with Sanara Medtech Valuation or Volatility modules.
Sanara | Operating Cycle | Build AI portfolio with Sanara Stock |
The Operating Cycle trend for Sanara Medtech offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Sanara Medtech is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Sanara Medtech's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Sanara Medtech over the last few years. It is Sanara Medtech's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sanara Medtech's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Sanara Operating Cycle Regression Statistics
| Arithmetic Mean | 263.88 | |
| Geometric Mean | 254.04 | |
| Coefficient Of Variation | 27.94 | |
| Mean Deviation | 59.41 | |
| Median | 266.74 | |
| Standard Deviation | 73.72 | |
| Sample Variance | 5,434 | |
| Range | 241 | |
| R-Value | 0.33 | |
| Mean Square Error | 5,184 | |
| R-Squared | 0.11 | |
| Significance | 0.20 | |
| Slope | 4.74 | |
| Total Sum of Squares | 86,944 |
Sanara Operating Cycle History
About Sanara Medtech Financial Statements
Investors use fundamental indicators, such as Sanara Medtech's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Sanara Medtech's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 207.59 | 385.53 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Sanara Medtech Correlation against competitors. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is there potential for Health Care Equipment & Supplies market expansion? Will Sanara introduce new products? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Revenue Per Share | Quarterly Revenue Growth 0.215 | Return On Assets | Return On Equity |
The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sanara Medtech's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.